Moderna
The latest news about Moderna: headlines, AI summaries and the full story from every source.
- Moderna Added to Nasdaq-100 Index, Impact on Investors
- Moderna's Market Cap Surpasses BioNTech by Over Three Times Amid Diverging Biotech Pipelines
- Moderna Stock Surges Over 14% on New Cancer Research Initiative
- Citi Downgrades Moderna to Sell Amid Concerns Over Stock Valuation
- Moderna Stock Surges Over 550% Amid Cancer Vaccine Hype; Is It Too Late to Buy?
- Moderna Reaches New High Ahead of Upcoming Pipeline Updates
- Wall Street Analysts Remain Cautious on Moderna Stock Despite Recent Gains
- Moderna's Stock Rises on Strong Momentum from Cancer Vaccine Data
- Moderna's Cancer Vaccine Shows Promising Phase 3 Results
- Moderna Surges 8% Amid Momentum Despite Lack of New Catalyst
- Moderna's Stock Soars Over Fivefold This Year Amid Clinical Milestones
- Rothschild & Co. Downgrades Moderna to Sell Amid Concern Over Stock Valuation
- Moderna's Recent Surge Amid Cancer Vaccine Trial Success
- Moderna Stock Surges 127% on Positive Cancer Vaccine Trial Results
- Moderna Shares Rise Over 14% Following Trial Results
- Schwab U.S. Dividend Equity ETF (SCHD) Sees $679M Inflows Amid Strong Performance
- Moderna Stock Surges on Positive Phase 3 Melanoma Trial Results
- Moderna Shares Soar on Cancer Vaccine Results; Target and Lowe's Report Tariff Refund Impacts
- Moderna Surges 14% Amid FDA Vaccine Endorsement and Strong Q1 Performance
- Moderna Shares Drop After Six-Session Winning Streak
- Moderna Surges 94% in 2026 Amid Leadership Restructuring and Upcoming Product Launches
- Moderna Shares Rise Ahead of Upcoming Conference and Pipeline Updates
- Biotech Stocks Rally Amid Hantavirus Concerns
- Tech Stocks Rise on Strong Apple Earnings and AI Optimism
- Moderna Exceeds Revenue Estimates with Strong International COVID Vaccine Sales
- CureVac Files Patent Infringement Lawsuit Against Moderna Over mRNA Vaccine Technology
- Moderna's Q1 2026 Earnings Outlook and Financial Performance